Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma

We previously reported that tumour-associated caveolin-1 is a potential biomarker in renal cell carcinoma (RCC), whose overexpression predicts metastasis following surgical resection for clinically confined disease. Much attention has recently focused on the AKT/mTOR pathway in a number of malignanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, L, Jasani, B, Edwards, K, Gumbleton, M, Griffiths, D F R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266860/
https://www.ncbi.nlm.nih.gov/pubmed/18283322
http://dx.doi.org/10.1038/sj.bjc.6604243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266860/
https://www.ncbi.nlm.nih.gov/pubmed/18283322
http://dx.doi.org/10.1038/sj.bjc.6604243

Ejemplares similares